Sutro Biopharma
STRO
STRO
80 hedge funds and large institutions have $189M invested in Sutro Biopharma in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
16.27% more ownership
Funds ownership: 51.64% → 67.9% (+16%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
80
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$14.9M | |
| 2 | +$14.7M | |
| 3 | +$14.2M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$11.6M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$6.38M |
Top Sellers
| 1 | -$2.16M | |
| 2 | -$1.74M | |
| 3 | -$1.07M | |
| 4 |
VM
VV Manager
Boston,
Massachusetts
|
-$770K |
| 5 |
JPMorgan Chase & Co
New York
|
-$151K |